Liver cirrhosis
Conditions
Interventions
Autologuous adipose derived mesenchymal stem cell infusion via hepatic artery.
Sponsors
Itano Satoshi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria 1.Clinically diagnosed as cirrhosis by CT and blood tests. 2.Child-Pugh score must be 6 points or more. 3.Must be between 20 and 90 years old. 4.Prior written consent to participate in the study must be obtained in writing.
Exclusion criteria
Exclusion criteria: Exclusion criteria A. Patients whose abstinence cannot be expected during the treatment period B. Patients with severe heart disease (obvious heart failure and arrhythmia) C. Patients with hypersensitivity to the anesthetic used when collecting adipose tissue D. Patients with uncontrolled malignant or intraepithelial neoplasia E. Patients with uncontrollable infections F. Pregnant women, lactating and possibly pregnant G. Patients taking birth control pills H. Patients who cannot give their informed consent I. Patients who cannot evaluate the efficacy J. Patients who can undergo other effective treatments, liver transplantation (living body and brain death) K. Other patients who are judged to be inappropriate by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of liver function | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of liver fibrosis | — |
Countries
Japan
Contacts
Public ContactKenji Yoshida
Kurume chuo hospital
Outcome results
None listed